To strengthen this point we stratified for tumor cell genetic markers such as TP53, ERBB2 and ARID1A/SWI/SNF which would disregard corresponding tumor cell endogenous signaling pathways as the main driver of these effects. This evidence concerns the gene ERBB2 and neoplasm.